Treating the circulation, not just a number: perfusion-based assessment, the limits of the "MAP = gestational age" rule, and a stepwise approach to volume, inotropes, and hydrocortisone — built on West Midlands Neonatal Guidelines 2025–28 and current hemodynamic evidence
Neonatal blood-pressure management is one of the most nuanced areas in the NICU. Blood pressure is only a surrogate for the real goal — adequate tissue perfusion and oxygen delivery. A given number may be normal for one infant and inadequate for another, and treating an isolated low reading with fluids and pressors can cause harm. The modern approach is to assess perfusion, identify the mechanism, and treat the cause with a targeted, stepwise strategy.
Both under- and over-treatment carry risk: inadequate perfusion contributes to organ injury (including IVH), while inappropriate fluid boluses and pressors are associated with harm. There is no consensus BP threshold in preterm infants, making perfusion-based, mechanism-targeted care essential.
| Term | Definition |
|---|---|
| Hypotension | Blood pressure below a defined threshold — but no single threshold reliably defines inadequate perfusion. |
| "MAP ≥ gestational age" rule | A rough guide (mean arterial pressure in mmHg ≥ completed weeks) — a starting reference, not a treatment trigger. |
| Shock | Inadequate tissue perfusion/oxygen delivery; may occur with normal or low blood pressure. |
| Vasopressor-resistant hypotension | Hypotension persisting despite volume and adequate inotrope/vasopressor doses; consider adrenal insufficiency. |
| Mechanism | Examples | Targeted treatment |
|---|---|---|
| Hypovolemia | Acute blood loss (abruption, feto-maternal, subgaleal), dehydration. | Volume replacement (± blood for hemorrhage). |
| Myocardial dysfunction | Asphyxia, sepsis, PPHN, metabolic. | Inotrope (e.g., dobutamine); treat cause. |
| Vasodilation/distributive | Sepsis, vasodilatory shock. | Vasopressor; antibiotics; consider steroids if refractory. |
| Obstructive | Tension pneumothorax, tamponade, duct-dependent lesion. | Relieve obstruction (decompress; prostaglandin). |
| Adrenal insufficiency | Relative adrenal insufficiency (preterm/critically ill). | Hydrocortisone. |
Choose the agent to match the mechanism; titrate to perfusion and blood pressure per local policy.
| Agent | Main effect | Typical role |
|---|---|---|
| Dopamine | Inotrope/vasopressor (dose-dependent). | Common first-line for hypotension. |
| Dobutamine | Inotrope (improves contractility/output). | Myocardial dysfunction/low output. |
| Adrenaline (epinephrine) | Potent inotrope/vasopressor. | Refractory shock. |
| Noradrenaline (norepinephrine) | Vasopressor. | Vasodilatory/septic shock. |
| Milrinone | Inodilator. | Selected low-output/PPHN states (specialist). |
All vasoactive infusion doses, dilutions, and titration must follow the Neonatal Formulary and local policy — flagged for expert review.
| Parameter | Frequency | Action |
|---|---|---|
| Perfusion (cap refill, lactate, urine output) | Continuous/serial | Guide escalation/de-escalation. |
| Blood pressure (ideally invasive) | Continuous in shock | Titrate support; interpret with perfusion. |
| Echocardiography (functional) | As available | Define mechanism; guide agent choice. |
| Glucose/electrolytes | Regular | Detect steroid effects; support metabolism. |
| Cause-specific (cultures, imaging) | As indicated | Treat sepsis/PDA/pneumothorax/hemorrhage. |
| Mistake | Why it harms | Better practice |
|---|---|---|
| Treating the number alone. | Over/under-treatment. | Assess perfusion and mechanism. |
| Repeated boluses in preterm. | IVH/BPD risk. | Judicious volume; reassess. |
| Wrong agent for physiology. | Ineffective/harmful. | Match agent to mechanism. |
| Missing obstructive/reversible cause. | Ongoing shock. | Decompress; prostaglandin; treat sepsis. |
| Forgetting adrenal insufficiency. | Refractory hypotension. | Consider hydrocortisone. |